acetyl l carnitine and l theanine L-Carnitine Acetyl L-Carnitine, 500 mg, 60

as a control) intraperitoneally every day to EAAC1 KO mice from 5 weeks of age (5 W) to 8 or 12 W to examine whether NAC can prevent the NTG-like phenotypes in EAAC1 KO mice (Fig

Comprehensive overview of pharmacology, dosing, and clinical use

Yet, despite the relatively small scale of the study, donor sexes were equally accounted for as relevant biological variables, with an observed minimal impact (especially on carnitine metabolism) compared to that of storage temperatures and additives in this pilot analysis

These findings suggest that the two groups may have distinct health profiles and socio-demographic characteristics, which could influence health outcomes